Opportunity Information: Apply for CDC RFA CE16 1601
Apply for CDC RFA CE16 1601
- The HHS-CDC in the health sector is offering a public funding opportunity titled "The Prevention and Control of Unintentional Injury and Violence Prevention Through the World Health Organization" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.136.
- This funding opportunity was created on Feb 22, 2016 and posted on Feb 22, 2016.
- Applicants must submit their applications by Jun 01, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "The Prevention and Control of Unintentional Injury and Violence Prevention Through the World Health Organization" (Funding Opportunity Number CDC RFA CE16-1601) is a CDC-funded cooperative agreement intended to reduce the global burden of violence and unintentional injuries, with a particular emphasis on low- and middle-income countries. Even though the work is international in scope, it is framed to support the Healthy People 2020 priority area focused on preventing injury and violence. In practical terms, the program is designed to strengthen how countries and public health partners track injuries and violence, build local capacity to prevent them, and spread proven methods and tools that practitioners can use in real-world settings.
A major focus of the opportunity is improving data and monitoring. The recipient is expected to support the development and use of indicators and surveillance systems that can reliably measure injuries and violence and track trends over time. That includes helping establish or strengthen reporting systems, improving the quality and consistency of injury and violence data, and making sure information collected is actually useful for decision-making. Better surveillance is treated as foundational, because countries need clear, comparable data to identify the biggest problems, target interventions, and evaluate whether prevention strategies are working.
Capacity building is another core element. The opportunity emphasizes training and education aimed at professionals and institutions involved in injury and violence prevention. This can include developing educational materials, conducting workshops or technical trainings, and helping build long-term expertise within public health systems and partner organizations. The intent is not just one-time training, but strengthening the ability of local and national partners to design, implement, and sustain prevention efforts over time.
The grant also supports implementation and evaluation of comprehensive prevention strategies. Rather than focusing on isolated projects, the language points to broader, coordinated approaches to preventing and controlling injuries and violence. The recipient is expected to help roll out strategies in low- and middle-income countries and assess their effectiveness, which typically involves defining measurable outcomes, monitoring implementation quality, and documenting results so that successful approaches can be adapted or scaled in other settings. Evaluation is positioned as a key requirement because it helps translate prevention work into evidence that can guide policy, funding decisions, and program improvements.
Dissemination is treated as a central deliverable. The recipient will be responsible for spreading information, tools, and expertise that support injury and violence prevention, making them accessible for practitioners who need them. This may include producing guidance documents, toolkits, protocols, technical resources, and communication products that translate technical knowledge into practical steps. The opportunity also highlights partnership development, meaning the recipient should build and maintain relationships across relevant stakeholders, including international bodies, government agencies, public health programs, and other organizations involved in injury and violence prevention.
Administratively, this is a discretionary funding opportunity from HHS/CDC using a cooperative agreement mechanism, which typically implies ongoing collaboration with CDC during the project period rather than a hands-off grant. The CFDA number associated with the program is 93.136. The posting date and creation date were both February 22, 2016, and the closing date was June 1, 2016. The opportunity anticipated a single award (Expected Awards: 1). The listing shows an award ceiling of 0, which usually means the ceiling was not specified in the public summary or depended on factors described in the full announcement. Eligibility is categorized as "Others (see text field entitled Additional Information on Eligibility for clarification)," indicating that the detailed eligibility rules were provided in the full funding announcement rather than in the brief summary.
Overall, the opportunity is aimed at building stronger global systems for preventing violence and unintentional injury by improving surveillance and indicators, expanding training and technical capacity, supporting implementation and evaluation of comprehensive prevention strategies, and widely sharing usable tools and expertise. The end goal is practical impact: giving practitioners and public health systems the resources and partnerships they need to reduce injury and violence in settings where the burden is often highest and prevention infrastructure may be limited.
Frequently Asked Questions (FAQs)
1) What is the title of this grant opportunity?
The opportunity is titled "The Prevention and Control of Unintentional Injury and Violence Prevention Through the World Health Organization."
2) What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA CE16-1601.
3) Which agency is offering this funding?
This is a discretionary funding opportunity from HHS/CDC (the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention).
4) What funding mechanism is used?
The award is a cooperative agreement, which generally means the recipient should expect ongoing collaboration with CDC during the project period rather than a fully hands-off grant relationship.
5) What is the program’s CFDA number?
The CFDA number associated with this program is 93.136.
6) What is the overall purpose of the opportunity?
The purpose is to reduce the global burden of violence and unintentional injuries, with a particular emphasis on low- and middle-income countries, by strengthening surveillance and indicators, building prevention capacity, supporting implementation and evaluation of prevention strategies, and disseminating practical tools and knowledge.
7) Is the work domestic or international in scope?
The work is international in scope, with particular emphasis on low- and middle-income countries.
8) How does this opportunity connect to Healthy People 2020?
Even though the work is global, it is framed to support the Healthy People 2020 priority area focused on preventing injury and violence.
9) What kinds of public health problems does the grant focus on?
The focus is on violence and unintentional injuries, with an emphasis on prevention and control through stronger public health systems and partnerships.
10) What are the main program activities emphasized in the summary?
The summary emphasizes four major activity areas: (1) improving data, indicators, and monitoring/surveillance; (2) capacity building through training and education; (3) implementation and evaluation of comprehensive prevention strategies; and (4) dissemination of tools, resources, and expertise, along with partnership development.
11) Why is surveillance and monitoring such a central focus?
Because clear, comparable data is treated as foundational for identifying the biggest injury and violence problems, targeting interventions, tracking trends over time, and evaluating whether prevention strategies are working.
12) What does “improving data and monitoring” include?
It includes supporting the development and use of indicators and surveillance systems, helping establish or strengthen reporting systems, improving the quality and consistency of injury and violence data, and making sure the information collected is useful for decision-making.
13) What is meant by “indicators” in this opportunity?
Indicators refer to measurable metrics used to reliably measure injuries and violence and track trends over time, supported through the development and use of surveillance systems.
14) What is meant by “surveillance systems” in this context?
Surveillance systems are the reporting and monitoring mechanisms used to collect and analyze injury and violence data in a consistent way over time so trends can be tracked and programs can be guided by evidence.
15) What types of capacity building does the opportunity support?
Capacity building includes training and education for professionals and institutions involved in injury and violence prevention, such as developing educational materials, conducting workshops, offering technical trainings, and building long-term expertise within public health systems and partner organizations.
16) Is the training expected to be one-time or long-term?
The intent is not just one-time training. The emphasis is on strengthening the ability of local and national partners to design, implement, and sustain prevention efforts over time.
17) What does the opportunity say about prevention strategies to be implemented?
It supports implementation and evaluation of comprehensive prevention strategies, emphasizing broader, coordinated approaches rather than isolated projects.
18) What does “comprehensive prevention strategies” imply here?
It points to coordinated, broader approaches to preventing and controlling injuries and violence, rather than a collection of unrelated or stand-alone activities.
19) Is evaluation required or optional?
Evaluation is positioned as a key requirement. The recipient is expected to assess effectiveness by defining measurable outcomes, monitoring implementation quality, and documenting results.
20) Why is evaluation emphasized?
Because evaluation helps translate prevention work into evidence that can guide policy, funding decisions, and program improvements, and supports adaptation or scaling of successful approaches.
21) What is meant by “dissemination” in this opportunity?
Dissemination is a central deliverable focused on spreading information, tools, and expertise that practitioners can use in real-world settings to support injury and violence prevention.
22) What kinds of dissemination products are mentioned?
Examples include guidance documents, toolkits, protocols, technical resources, and communication products that translate technical knowledge into practical steps.
23) Who is the intended audience for the disseminated tools and resources?
The materials are intended to be accessible and usable for practitioners and public health partners working on injury and violence prevention.
24) What role do partnerships play in this opportunity?
Partnership development is highlighted as part of the work. The recipient is expected to build and maintain relationships across stakeholders such as international bodies, government agencies, public health programs, and other organizations involved in injury and violence prevention.
25) How many awards were expected?
The opportunity anticipated a single award (Expected Awards: 1).
26) What was the posting date for the opportunity?
The posting date was February 22, 2016.
27) What was the creation date for the opportunity?
The creation date was February 22, 2016.
28) What was the application closing date?
The closing date was June 1, 2016.
29) Was an award ceiling listed?
The listing shows an award ceiling of 0, which typically indicates the ceiling was not specified in the public summary or depended on details described in the full announcement.
30) Who was eligible to apply based on the summary?
Eligibility is categorized as "Others (see text field entitled Additional Information on Eligibility for clarification)," meaning the detailed eligibility rules were provided in the full funding announcement rather than in the brief summary.
31) Does the summary specify exactly which organizations qualify under “Others”?
No. The summary points to an "Additional Information on Eligibility" section in the full announcement for clarification, but those details are not included in the provided summary.
32) What practical outcomes is this program aiming to achieve?
The end goal is practical impact: stronger systems and partnerships that give practitioners and public health programs the data, skills, tools, and evidence needed to reduce injury and violence, especially in settings where the burden is high and prevention infrastructure may be limited.
Browse more opportunities from the same agency: HHS-CDC
Browse more opportunities from the same category: Health
Next opportunity: Urban and Non-Urban Homeless Veterans’ Reintegration Program (HVRP) and Incarcerated Veterans Transition Program (IVTP) (referred together throughout this funding opportunity announcement as HVRP)
Previous opportunity: Cooperative Ecosystem Studies Unit, Californian CESU
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA CE16 1601
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA CE16 1601) also looked into and applied for these:
| Funding Opportunity |
|---|
| PPHF16: Heart Disease & Stroke Prevention Program and Diabetes Prevention – State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke – Financed Solely by 2016 Prevention and Public Health Funds Apply for CDC RFA DP14 142203PPHF16 Funding Number: CDC RFA DP14 142203PPHF16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Modeling of Infectious Disease Agent Study Research Projects (R01) Apply for PA 16 107 Funding Number: PA 16 107 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Evidence-Based Falls Prevention Programs in Tribal Communities Financed Solely by 2016 Prevention and Public Health Funds (PPHF-2016) Apply for HHS 2016 ACL AOA FP 0133 Funding Number: HHS 2016 ACL AOA FP 0133 Agency: HHS-ACL Category: Health Funding Amount: $150,000 |
| Enhancing Cancer Registries for Early Case Capture of Pediatric and Young Adult Cancer Cases Apply for CDC RFA DP14 140203CONT16 Funding Number: CDC RFA DP14 140203CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Developmental Behavioral Pediatrics Research Network Apply for HRSA 16 039 Funding Number: HRSA 16 039 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Biomarkers Discovery In Parkinsonism (U01) Apply for PAR 16 112 Funding Number: PAR 16 112 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| National Organizations’ Support for State Oral Health Programs Apply for CDC RFA DP13 131304CONT16 Funding Number: CDC RFA DP13 131304CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Characterization of Circulating Pro- and Anti-Geronic Proteins and Peptides (R01) Apply for RFA AG 17 002 Funding Number: RFA AG 17 002 Agency: HHS-NIH11 Category: Health Funding Amount: $350,000 |
| Maximizing Access to Research Careers Undergraduate - Student Training in Academic Research (MARC U-STAR) (T34) Apply for PAR 16 113 Funding Number: PAR 16 113 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Improving Fetal Alcohol Spectrum Disorders Prevention and Practice through National Partnerships Apply for CDC RFA DD14 140303CONT16 Funding Number: CDC RFA DD14 140303CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Center without Walls for the Identification and Validation of Molecular Mechanisms Contributing to Tau Pathogenesis and Associated Neurodegeneration in Frontotemporal Degeneration (FTD) (U54) Apply for RFA NS 16 023 Funding Number: RFA NS 16 023 Agency: HHS-NIH11 Category: Health Funding Amount: $1,500,000 |
| Empowering Older Adults and Adults with Disabilities in Tribal Communities through Chronic Disease Self-Management Education Programs Financed Solely by 2016 Prevention and Public Health Funds (PPHF-2016) Apply for HHS 2016 ACL AOA CS 0129 Funding Number: HHS 2016 ACL AOA CS 0129 Agency: HHS-ACL Category: Health Funding Amount: $150,000 |
| Cooperative Study Group for Autoimmune Disease Prevention (U01) Apply for RFA AI 16 003 Funding Number: RFA AI 16 003 Agency: HHS-NIH11 Category: Health Funding Amount: $1,600,000 |
| Stimulating Peripheral Activity to Relieve Conditions (SPARC): Pre-clinical Development of Existing Market-approved Devices to Support New Market Indications (U18) Apply for RFA RM 16 009 Funding Number: RFA RM 16 009 Agency: HHS-NIH11 Category: Health Funding Amount: $400,000 |
| Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Apply for CDC RFA DD15 150702CONT16 Funding Number: CDC RFA DD15 150702CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement with the Chinese Center for Disease Control and Prevention Apply for CDC RFA GH12 124705CONT16 Funding Number: CDC RFA GH12 124705CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir (R01) Apply for PAR 16 115 Funding Number: PAR 16 115 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Addiction Technology Transfer Center: Networking Coordinating Office for Internationally-based Addiction Technology Transfer Centers (Short Title: Global-ATTC) Apply for TI 16 015 Funding Number: TI 16 015 Agency: HHS-SAMHS Category: Health Funding Amount: $100,000 |
| Small Vessel Vascular Contributions to Cognitive Impairment and Dementia (VCID) Biomarkers Consortium: Coordinating Center (U24) Apply for RFA NS 16 019 Funding Number: RFA NS 16 019 Agency: HHS-NIH11 Category: Health Funding Amount: $750,000 |
| Enhancing Cancer Genomic Best Practices through Education, Surveillance, and Policy Apply for CDC RFA DP14 140703CONT16 Funding Number: CDC RFA DP14 140703CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA CE16 1601", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
